#BEGIN_DRUGCARD DB03997

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
16996

# Chemical_Formula:
C6H11N3O4P

# Chemical_IUPAC_Name:
[(2R)-2-amino-3-(imidazol-4-yl)propoxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester

# HET_ID:
HSA

# Half_Life:
Not Available

# InChI_Identifier:
Not Available

# InChI_Key:
Not Available

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3997

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
220.143

# Molecular_Weight_Mono:
220.048717367

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GEX

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.7

# Predicted_LogS:
-0.89

# Predicted_Water_Solubility:
2.85e+01 g/l

# Primary_Accession_No:
DB03997

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6326760

# PubChem_Substance_ID:
46508216

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01781

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](COP(O)(O)=O)Cc1cncn1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:50 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X03416

# Drug_Target_1_GenBank_ID_Protein:
41695

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hisC

# Drug_Target_1_Gene_Sequence:
>1071 bp
ATGAGCACCGTGACTATTACCGATTTAGCGCGTGAAAACGTCCGCAACCTGACGCCGTAT
CAGTCGGCGCGTCGTCTGGGCGGTAACGGCGATGTCTGGCTGAACGCCAACGAATACCCC
ACTGCCGTGGAGTTTCAGCTTACTCAGCAAACGCTCAACCGCTACCCGGAATGCCAGCCG
AAAGCGGTGATTGAAAATTACGCGCAATATGCAGGCGTAAAACCGGAGCAGGTGCTGGTC
AGCCGTGGCGCGGACGAAGGTATTGAACTGCTGATTCGCGCTTTTTGCGAACCGGGTAAA
GACGCCATCCTCTACTGCCCGCCAACGTACGGCATGTACAGCGTCAGCGCCGAAACGATT
GGCGTCGAGTGTCGCACAGTGCCGACGCCGGACAACTGGCAACTGGACTTACAGGGCATT
TCCGACAAGCTGGACGGCGTAAAAGCGGTTTATGTTTGCAGCCCCAATAACCCGACCGGG
CAACTGATCAATCCGCAGGATTTTCGCACCCTGCTGGAGTTAACCCGCGGTAAGGCGATT
GTGGTTGCCGATGAAGCCTATATCGAGTTTTGCCCGCAGGCATCGCTGGCTGGCTGGCTG
GCGGAATATCCGCACCTGGCTATTTTACGCACACTGTCGAAAGCTTTTGCTCTGGCGGGG
CTTCGTTGCGGATTTACGCTGGCAAACGAAGAAGTCATCAACCTGCTGATGAAAGTGATC
GCCCCCTACCCGCTCTCGACGCCGGTTGCCGACATTGCGGCCCAGGCGTTAAGCCCACAG
GGAATCGTCGCCATGCGCGAACGGGTAGCGCAAATTATTGCAGAACGCGAATACCTGATT
GCCGCACTGAAAGAGATCCCCTGCGTAGAGCAGGTTTTCGACTCTGAAACCAACTACATT
CTGGCGCGCTTTAAAGCCTCCAGTGCGGTGTTTAAATCTTTGTGGGATCAGGGCATTATC
TTACGTGATCAGAATAAACAACCCTCTTTAAGCGGCTGCCTGCGAATTACCGTCGGAACC
CGTGAAGAAAGCCAGCGCGTCATTGACGCCTTACGTGCGGAGCAAGTTTGA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
11294630	Haruyama K, Nakai T, Miyahara I, Hirotsu K, Mizuguchi H, Hayashi H, Kagamiyama H: Structures of Escherichia coli histidinol-phosphate aminotransferase and its complexes with histidinol-phosphate and N-(5'-phosphopyridoxyl)-L-glutamate: double substrate recognition of the enzyme. Biochemistry. 2001 Apr 17;40(15):4633-44.
11518529	Sivaraman J, Li Y, Larocque R, Schrag JD, Cygler M, Matte A: Crystal structure of histidinol phosphate aminotransferase (HisC) from Escherichia coli, and its covalent complex with pyridoxal-5'-phosphate and l-histidinol phosphate. J Mol Biol. 2001 Aug 24;311(4):761-76.
2999081	Grisolia V, Carlomagno MS, Nappo AG, Bruni CB: Cloning, structure, and expression of the Escherichia coli K-12 hisC gene. J Bacteriol. 1985 Dec;164(3):1317-23.
3062174	Carlomagno MS, Chiariotti L, Alifano P, Nappo AG, Bruni CB: Structure and function of the Salmonella typhimurium and Escherichia coli K-12 histidine operons. J Mol Biol. 1988 Oct 5;203(3):585-606.
8201624	Jovanovic G, Kostic T, Jankovic M, Savic DJ: Nucleotide sequence of the Escherichia coli K12 histidine operon revisited. J Mol Biol. 1994 Jun 10;239(3):433-5.
9097040	Itoh T, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Kasai H, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Seki Y, Horiuchi T, et al.: A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40.1-50.0 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):379-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2546

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
39361

# Drug_Target_1_Name:
Histidinol-phosphate aminotransferase

# Drug_Target_1_Number_of_Residues:
356

# Drug_Target_1_PDB_ID:
1GEY

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00155	Aminotran_1_2

# Drug_Target_1_Protein_Sequence:
>Histidinol-phosphate aminotransferase
MSTVTITDLARENVRNLTPYQSARRLGGNGDVWLNANEYPTAVEFQLTQQTLNRYPECQP
KAVIENYAQYAGVKPEQVLVSRGADEGIELLIRAFCEPGKDAILYCPPTYGMYSVSAETI
GVECRTVPTLDNWQLDLQGISDKLDGVKVVYVCSPNNPTGQLINPQDFRTLLELTRGKAI
VVADEAYIEFCPQASLAGWLAEYPHLAILRTLSKAFALAGLRCGFTLANEEVINLLMKVI
APYPLSTPVADIAAQALSPQGIVAMRERVAQIIAEREYLIAALKEIPCVEQVFDSETNYI
LARFKASSAVFKSLWDQGIILRDQNKQPSLSGCLRITVGTREESQRVIDALRAEQV

# Drug_Target_1_Reaction:
L-histidinol phosphate + 2-oxoglutarate = 3-(imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
L-histidinol phosphate + 2-oxoglutarate = 3- (imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_1_SwissProt_ID:
P06986

# Drug_Target_1_SwissProt_Name:
HIS8_ECOLI

# Drug_Target_1_Synonyms:
EC 2.6.1.9
HPAT
HspAT
Imidazole acetol- phosphate transaminase

# Drug_Target_1_Theoretical_pI:
4.72

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE000512

# Drug_Target_2_GenBank_ID_Protein:
4981580

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
hisC

# Drug_Target_2_Gene_Sequence:
>1008 bp
TCATTTGAACACCTCCAGTTCTCTCAGAATCATATCGTTCTCTTCGCGTTTTCCGATAGT
GATTCTAACACCTTCCCTGAAACTGCGAACAGCGACGTTCTTCGTCCGGAGGTGTTCGAG
AAGTCTTTCTTTTTCTTCCTTCTCCATGAATACGAACACGAAGTTTCCTCTGGAGTCGGT
GATTCGGTATCCCATTTCCCTGAGAGCACTCTTCATCCTCTCGCGTTCTTCCACGATGAA
CTTCGTTCTTTCTTCAAAGATCTCTCTGTGATCGAGAGCTACCTTTGCGAACATCTGGGA
GACGTAGCTCACGTTGAAAGGAAGTCTCACCCTGTTGTAAGCGTCAATGAACTTCTCCGA
GGCCACAACGTATCCGACACGTTGCGCTGCCAGGGAAAACGCTTTCGAGAAAGTCCTGAT
CACAGCGAGATTTTCGTATTTCTTCAGAAAATCCACATAACTTTCTCCGTGGAATTCGTA
GTAGGCTTCGTCCAGCGCGACGAAGGCACCCGTTTTCAGGATTCTTTCTATTTCCTCTCT
TTCGAAGACATGGCCCGTTGGATTGTTCGGGTTCGGAATGAAAACAACGTCTCCTTCTCC
CACGTTCACCTCAGGTATCCTCAGATCTTTCGTGAGCGGCACTTCCAGGAATTTCGCTCC
AACTGCCTTCGCAAAGATCCTGTAGCAGCTGTAGGTCGGGGGAAAGAAAACGGAACGGTC
GAACATGAGCATCATCACGTAGATGATCTCATCCGCTCCGTTTCCCACAGAGACGTTGTT
TTTCGAAAGAAAATCGGTGTCGAGGTATGAGAGTATCTTTTCTATTAATTCTTCATCGGG
GGAGTCGTAGTAGATCCTCAGGGCGTCGCTGTTCAATCGTCGAAACACTTCATCCACGAG
GTCCTCTGGAAAGGGAAACGGATTTTCATTCAGCGCAAGGTAGGTTTTGTCTCTCTTTTC
GGTTTCGTACGGATACGCCCTCTTTGCAATCAAATCGAGAGGATTCAC

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2698

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
39298

# Drug_Target_2_Name:
Histidinol-phosphate aminotransferase

# Drug_Target_2_Number_of_Residues:
335

# Drug_Target_2_PDB_ID:
1UU2

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00155	Aminotran_1_2

# Drug_Target_2_Protein_Sequence:
>Histidinol-phosphate aminotransferase
MNPLDLIAKRAYPYETEKRDKTYLALNENPFPFPEDLVDEVFRRLNSDALRIYYDSPDEE
LIEKILSYLDTDFLSKNNVSVGNGADEIIYVMMLMFDRSVFFPPTYSCYRIFAKAVGAKF
LEVPLTKDLRIPEVNVGEGDVVFIPNPNNPTGHVFEREEIERILKTGAFVALDEAYYEFH
GESYVDFLKKYENLAVIRTFSKAFSLAAQRVGYVVASEKFIDAYNRVRLPFNVSYVSQMF
AKVALDHREIFEERTKFIVEERERMKSALREMGYRITDSRGNFVFVFMEKEEKERLLEHL
RTKNVAVRSFREGVRITIGKREENDMILRELEVFK

# Drug_Target_2_Reaction:
L-histidinol phosphate + 2-oxoglutarate = 3-(imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
L-histidinol phosphate + 2-oxoglutarate = 3- (imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_2_SwissProt_ID:
Q9X0D0

# Drug_Target_2_SwissProt_Name:
HIS8_THEMA

# Drug_Target_2_Synonyms:
EC 2.6.1.9
Imidazole acetol- phosphate transaminase

# Drug_Target_2_Theoretical_pI:
5.15

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03997
